Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Journey Medical Corp 9237 E VIA DE VENTURA BLVD. SUITE 105 SCOTTSDALE AZ 85258 USA

www.jmcderm.com Employees: 41 P: 480-434-6670

Sector:

Medical

Description:

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

Key Statistics

Overview:

Market Capitalization, $K 202,163
Enterprise Value, $K 206,733
Shares Outstanding, K 27,136
Annual Sales, $ 56,130 K
Annual Net Income, $ -14,670 K
Last Quarter Sales, $ 17,630 K
Last Quarter Net Income, $ -2,320 K
EBIT, $ -3,430 K
EBITDA, $ 300 K
60-Month Beta 0.81
% of Insider Shareholders 15.03%
% of Institutional Shareholders 7.25%
Float, K 23,057
% Float 84.97%
Short Interest 2,428
Short Float 8.95%
Short Volume Ratio 0.48

Growth:

1-Year Return 82.48%
3-Year Return 185.38%
5-Year Return 0.00%
5-Year Revenue Growth 60.74%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 11/12/25
Next Earnings Date 03/25/26
Earnings Per Share ttm -0.35
EPS Growth vs. Prev Qtr 43.75%
EPS Growth vs. Prev Year 25.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DERM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 28.56
Price/Earnings to Growth N/A
Return-on-Equity % -39.94%
Return-on-Assets % -10.45%
Profit Margin % -26.14%
Debt/Equity 0.97
Price/Sales 2.80
Price/Cash Flow N/A
Price/Book 7.85
Book Value/Share 0.98
Interest Coverage -4.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar